The effectiveness of the serum surfactant protein D (Sp-D) level to indicate lung injury in pulmonary embolism

Clinical Laboratory

Volumn 60, Issue 9, 2014, Pages 1457-1464

  Kati, Celal ^a   Alacam, Hasan ^a   Duran, Latif ^a   Guzel, Aygul ^a   Akdemir, Hizir Ufuk ^a   Sisman, Bulent ^b   Sahin, Canan ^c   Yavuz, Yucel ^a   Altintas, Nejat ^a   Murat, Naci ^a   Okuyucu, Ali ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Ataturk State Hospital   (Turkey)

^c Samsun Education and Research Hospital   (Turkey)

Author keywords

Modified geneva score; Pulmonary embolism; Surfactant protein D; Wells score

Indexed keywords

SURFACTANT PROTEIN D; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATELECTASIS; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENEVA SCORE; HIGH RISK PATIENT; HUMAN; HYPOXIA; IMMOBILIZATION; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; LUNG EMBOLISM; LUNG INJURY; MALE; PROBABILITY; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; TRICUSPID VALVE REGURGITATION; WELLS SCORE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; UPREGULATION;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG INJURY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84908099315     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2013.131009     Document Type: Article

References (45)

1. Girard P, Musset D, Parent F, Maitre S, Phlippoteau C, Simon-neau G. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest 1999;116: 903-8.
2. Kline JA. Thromboembolism. In: Tintinalli JE, Stapczynski S, Ma OJ, Cline DM, Cydulka RK, Meckler GD. Tintinalli's Emergency Medicine A Comprehensive Study Guide, 7th Edition, New York, Me Graw Hill Companies Inc., 2011, 430-41.
3. Moser KM. Venous thromboembolism. Am Rev Respir Dis 1990; 141: 235-49.
4. Abul Y, Eryuksel E, Celikel C, Tosuner Z, Yazici Z, Karakurt S. Endobronchial Metastasis of Malignant Melanoma Presenting with Dyspnea: Case Report and Literature Review. Turkiye Klin-ikleri J Med Sci 2011 ;31: 468-70.
5. Tanriover MD, Arsava BE, Emri AS. Pulmonary Embolism Due to Metal Coil: Case Report. Turkiye Klinikleri J Med Sci 2011; 31: 1551-3.
6. Stein PD, Beemath A, Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 2005;95: 1525-6.
7. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: Part I: Epidemiology, pathophysiology, and diagnosis. Circulation 2003; 108: 2726-9.
8. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83: 416-20.
9. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: The revised Geneva score. Ann Intern Med 2006;144: 165-71.
10. Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992;85: 462-8.
11. Elliott CG, Goldhaber SZ, Visani L, DeRosa M. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest 2000; 118: 33-8.
12. Stein PD, Goldhaber SZ, Henry JW, Miller AC. Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest 1996;109: 78-81.
13. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990;263: 2753-9.
14. Schoepf UJ, Holzknecht N, Helmberger TK, et al. Subsegmentai pulmonary emboli: Improved detection with thin-collimation multi-detector row spiral CT. Radiology 2002;222: 483-90.
15. Stein PD, Henry JW, Gottschalk A. Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: Relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology 1999;210: 689-91.
16. Schellhaass A, Walther A, Konstantinides S, Bottiger BW. The Diagnosis and Treatment of Acute Pulmonary Embolism. Dtsch Arztebl Int 2010;107: 589-95.
17. Casazza F, Bongarzoni A, Centonze F, Morpurgo M. Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism. Am J Cardiol 1997;79: 1433-5.
18. Potocki M, Breidthardt T, Mueller A, et al. Copeptin and risk stratification in patients with acute dyspnea. Crit Care 2010;14: R 213.
19. Righini M, Perrier A, De Moerloose P, Bounameaux H. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008;6: 1059-71.
20. Fujita M, Shannon JM, Ouchi H, Voelker DR, Nakanishi Y, Mason RJ. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005;31: 25-33.
21. Hill J, Heslop C, Man SF, et al. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J 2011;32: 1918-25.
22. Guzel A, Gunaydin M, Alacam H, et al. The role of iNOS inhibitors on lung injury induced by gastrointestinal decontamination agents aspiration J Mol Histol 2012;43: 351-60.
23. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: A systematic review. Am J Med 2010;123: 426-31.
24. Worsley DF, Alavi A, Aronchick JM, Chen JT, Greenspan RH, Ravin CE. Chest radiographic findings in patients with acute pulmonary embolism: Observations from the PIOPED Study. Radiology 1993;189: 133-6.
25. Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenograph, and electrocardiographic findings in patients with ute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991;100: 598-603.
26. Girard P, Sanchez O, Leroyer C, et al. Deep venous thrombosis in patients with acute pulmonary embolism: Prevalence, risk factors, and clinical significance. Chest 2005;128: 1593-600.
27. Marin F, Roldan V, Lip GYH. Fibrinolytic function and atrial fibrillation. Thrombosis Research 2003;109: 233-40.
28. Myers D, Jr., Farris D, Hawley A, et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108: 212-21.
29. Downing LJ, Wakefield TW, Strieter RM, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vase Surg 1997;25: 816-28.
30. Wakefield TW, Strieter RM, Schaub R, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. Journal of Vascular Surgery 2000;31: 309-22.
31. Frenette PS, Denis CV, Weiss L, et al. P-selectin glycoprotein li-gand 1 (PSGL-1) is expressed on platelets and can mediate plate-let-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-22.
32. Rauch U, Bonderman D, Bohrmann B, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD 15 and tissue factor. Blood 2000;96: 170-5.
33. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102: 136-44.
34. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000;98: 461-6.
35. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95: 1317-23.
36. Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of D-di-mer in the diagnosis of pulmonary embolism: A randomized trial. Ann Intern Med 2006;144: 812-21.
37. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med 2004; 140: 589-602.
38. Dunn KL, Wolf JP, Dorfman DM, Fitzpatrick P, Baker JL, Gold-haber SZ. Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol 2002;40: 1475-8.
39. Abul Y, Karakurt S, Ozben B, Toprak A, Celikel T. C-reactive protein in acute pulmonary embolism. J Investig Med 2011;59: 8-14.
40. Cooper TJ, Prothero DL, Gillett MG, et al. Laboratory investigation in the diagnosis of pulmonary thromboembolism. Q J Med 1992;83: 369-79.
41. Kokturk N, Kanbay A, Bukan N, Ekim N. The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia. Clin Appi Thromb Hemost 2011;17: 519-25.
42. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002;46: 398-404.
43. Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, van Golde LM, Geuze HJ. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40: 1589-97.
44. Kawasaki Y, Endo K, Suyama K, et al. Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatr Pulmonol 2011 ;46: 18-22.
45. Gunaydin M, Guzel A, Alacam H, et al. The effect of curcumin on lung injuries in a rat model induced by aspirating gastrointestinal decontamination agents. J Pediatr Surg 2012;47: 1669-76.